On November 8, 2021 Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, reported that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update about the Company’s progress at the following upcoming investor conferences (Press release, Black Diamond Therapeutics, NOV 8, 2021, View Source [SID1234594708]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Stifel 2021 Virtual Healthcare Conference. The corporate presentation will take place on Monday, November 15, 2021 at 4:40 PM ET.
The 2021 Jefferies London Healthcare Conference. The presentation will be available on-demand beginning Thursday, November 18, 2021, starting at 4:00 AM ET.
A webcast of the Stifel presentation can be accessed by visiting the investor relations section of the Company’s website, www.blackdiamondtherapeutics.com. A replay of each presentation will also be available and archived on the site for 30 days.